Nutritional Supplement Works Against Some Pancreatic Cancer Cells in Mice

0 Views
administrator
administrator
07/13/23

The dietary supplement gamma-linoleic acid can inhibit the growth of a subset of pancreatic cancer cells and selectively promote cancer cell death in mice, say Mayo Clinic researchers. The supplement, a fatty acid also known as GLA, worked particularly well when combined with the chemotherapy drug gemcitabine, the researchers say. The findings were presented today by Mayo Clinic pathologist Ruth Lupu, Ph.D., at the American Association for Cancer Research conference.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next